Home/BeyondSpring/Dr. Lan Huang

DL

Dr. Lan Huang

Co-Founder, Chief Executive Officer, and Chairwoman of the Board

Therapeutic Areas

Oncology Supportive Cancer Care

BeyondSpring Pipeline

Drug	Indication	Phase
Plinabulin + G-CSF	Prevention of Chemotherapy-Induced Neutropenia (CIN)	Phase 3
Plinabulin	Non-Small Cell Lung Cancer (NSCLC)	Phase 2/3
BPI-002	Undisclosed Oncology Target	Preclinical

Leadership Team at BeyondSpring

Dr. Ramon Mohanlal

Former Chief Medical Officer and EVP of Research & Development

Founder and Director

Dr. Douglas Blayney

Scientific Advisory Board Member, Professor at Stanford University

View full BeyondSpring profile